Follow the Science: How Big Pharma Misleads, Obscures, and Prevails

by Sharyl Attkisson

That adds up to a fantastically lucrative market for the makers of HIV medicine, like Gilead Sciences. Gilead has developed eleven HIV medications now on the market earning over $1.5 billion a month.